Solution to killer superbug found in Norway

Dec 31, 2009 By MARTHA MENDOZA and MARGIE MASON , Associated Press Writers

(AP) -- Aker University Hospital is a dingy place to heal. The floors are streaked and scratched. A light layer of dust coats the blood pressure monitors. A faint stench of urine and bleach wafts from a pile of soiled bedsheets dropped in a corner.

Look closer, however, at a microscopic level, and this place is pristine. There is no sign of a dangerous and contagious staph infection that killed tens of thousands of patients in the most sophisticated hospitals of Europe, North America and Asia this year, soaring virtually unchecked.

The reason: Norwegians stopped taking so many drugs.

Twenty-five years ago, Norwegians were also losing their lives to this bacteria. But Norway's public health system fought back with an aggressive program that made it the most infection-free country in the world. A key part of that program was cutting back severely on the use of antibiotics.

Now a spate of new studies from around the world prove that Norway's model can be replicated with extraordinary success, and public health experts are saying these deaths - 19,000 in the U.S. each year alone, more than from AIDS - are unnecessary.

"It's a very sad situation that in some places so many are dying from this, because we have shown here in Norway that Methicillin-resistant Staphylococcus aureus () can be controlled, and with not too much effort," said Jan Hendrik-Binder, Oslo's MRSA medical adviser. "But you have to take it seriously, you have to give it attention, and you must not give up."

The says is one of the leading public health threats on the planet. A six-month investigation by The Associated Press found overuse and misuse of medicines has led to mutations in once curable diseases like tuberculosis and malaria, making them harder and in some cases impossible to treat.

Now, in Norway's simple solution, there's a glimmer of hope.

---

Dr. John Birger Haug shuffles down Aker's scuffed corridors, patting the pocket of his baggy white scrubs. "My bible," the infectious disease specialist says, pulling out a little red Antibiotic Guide that details this country's impressive MRSA solution.

It's what's missing from this book - an array of antibiotics - that makes it so remarkable.

"There are times I must show these golden rules to our doctors and tell them they cannot prescribe something, but our patients do not suffer more and our nation, as a result, is mostly infection free," he says.

Norway's model is surprisingly straightforward.

- Norwegian doctors prescribe fewer antibiotics than any other country, so people do not have a chance to develop resistance to them.

- Patients with MRSA are isolated and medical staff who test positive stay at home.

- Doctors track each case of MRSA by its individual strain, interviewing patients about where they've been and who they've been with, testing anyone who has been in contact with them.

Haug unlocks the dispensary, a small room lined with boxes of pills, bottles of syrups and tubes of ointment. What's here? Medicines considered obsolete in many developed countries. What's not? Some of the newest, most expensive antibiotics, which aren't even registered for use in Norway, "because if we have them here, doctors will use them," he says.

He points to an antibiotic. "If I treated someone with an infection in Spain with this penicillin I would probably be thrown in jail," he says, "and rightly so because it's useless there."

Norwegians are sanguine about their coughs and colds, toughing it out through low-grade infections.

"We don't throw antibiotics at every person with a fever. We tell them to hang on, wait and see, and we give them a Tylenol to feel better," says Haug.

Convenience stores in downtown Oslo are stocked with an amazing and colorful array - 42 different brands at one downtown 7-Eleven - of soothing, but non-medicated, lozenges, sprays and tablets. All workers are paid on days they, or their children, stay home sick. And drug makers aren't allowed to advertise, reducing patient demands for prescription drugs.

In fact, most marketing here sends the opposite message: "Penicillin is not a cough medicine," says the tissue packet on the desk of Norway's MRSA control director, Dr. Petter Elstrom.

He recognizes his country is "unique in the world and best in the world" when it comes to MRSA. Less than 1 percent of health care providers are positive carriers of MRSA staph.

But Elstrom worries about the bacteria slipping in through other countries. Last year almost every diagnosed case in Norway came from someone who had been abroad.

"So far we've managed to contain it, but if we lose this, it will be a huge problem," he said. "To be very depressing about it, we might in some years be in a situation where MRSA is so endemic that we have to stop doing advanced surgeries, things like organ transplants, if we can't prevent infections. In the worst case scenario we are back to 1913, before we had antibiotics."

---

Forty years ago, a new spectrum of antibiotics enchanted officials, quickly quelling one infection after another. In wealthier countries that could afford them, patients and providers came to depend on antibiotics. Trouble was, the more antibiotics are consumed, the more resistant bacteria develop.

Norway responded swiftly to initial MRSA outbreaks in the 1980s by cutting antibiotic use. Thus while they got ahead of the infection, the rest of the world fell behind.

In Norway, MRSA has accounted for less than 1 percent of staph infections for years. That compares to 80 percent in Japan, the world leader in MRSA; 44 percent in Israel; and 38 percent in Greece.

In the U.S., cases have soared and MRSA cost $6 billion last year. Rates have gone up from 2 percent in 1974 to 63 percent in 2004. And in the United Kingdom, they rose from about 2 percent in the early 1990s to about 45 percent, although an aggressive control program is now starting to work.

About 1 percent of people in developed countries carry MRSA on their skin. Usually harmless, the bacteria can be deadly when they enter a body, often through a scratch. MRSA spreads rapidly in hospitals where sick people are more vulnerable, but there have been outbreaks in prisons, gyms, even on beaches. When dormant, the bacteria are easily detected by a quick nasal swab and destroyed by antibiotics.

Dr. John Jernigan at the U.S. Centers for Disease Control and Prevention said they incorporate some of Norway's solutions in varying degrees, and his agency "requires hospitals to move the needle, to show improvement, and if they don't show improvement they need to do more."

And if they don't?

"Nobody is accountable to our recommendations," he said, "but I assume hospitals and institutions are interested in doing the right thing."

Dr. Barry Farr, a retired epidemiologist who watched a successful MRSA control program launched 30 years ago at the University of Virginia's hospitals, blamed the CDC for clinging to past beliefs that hand washing is the best way to stop the spread of infections like MRSA. He says it's time to add screening and isolation methods to their controls.

The CDC needs to "eat a little crow and say, 'Yeah, it does work,'" he said. "There's example after example. We don't need another study. We need somebody to just do the right thing."

---

But can Norway's program really work elsewhere?

The answer lies in the busy laboratory of an aging little public hospital about 100 miles outside of London. It's here that microbiologist Dr. Lynne Liebowitz got tired of seeing the stunningly low Nordic MRSA rates while facing her own burgeoning cases.

So she turned Queen Elizabeth Hospital in Kings Lynn into a petri dish, asking doctors to almost completely stop using two antibiotics known for provoking MRSA infections.

One month later, the results were in: MRSA rates were tumbling. And they've continued to plummet. Five years ago, the hospital had 47 MRSA bloodstream infections. This year they've had one.

"I was shocked, shocked," says Liebowitz, bouncing onto her toes and grinning as colleagues nearby drip blood onto slides and peer through microscopes in the hospital laboratory.

When word spread of her success, Liebowitz's phone began to ring. So far she has replicated her experiment at four other hospitals, all with the same dramatic results.

"It's really very upsetting that some patients are dying from infections which could be prevented," she says. "It's wrong."

Around the world, various medical providers have also successfully adapted Norway's program with encouraging results. A medical center in Billings, Mont., cut MRSA infections by 89 percent by increasing screening, isolating patients and making all staff - not just doctors - responsible for increasing hygiene.

In Japan, with its cutting-edge technology and modern hospitals, about 17,000 people die from MRSA every year.

Dr. Satoshi Hori, chief infection control doctor at Juntendo University Hospital in Tokyo, says doctors overprescribe antibiotics because they are given financial incentives to push drugs on patients.

Hori now limits antibiotics only to patients who really need them and screens and isolates high-risk patients. So far his hospital has cut the number of MRSA cases by two-thirds.

In 2001, the CDC approached a Veterans Affairs hospital in Pittsburgh about conducting a small test program. It started in one unit, and within four years, the entire hospital was screening everyone who came through the door for MRSA. The result: an 80 percent decrease in MRSA infections. The program has now been expanded to all 153 VA hospitals, resulting in a 50 percent drop in MRSA bloodstream infections, said Dr. Robert Muder, chief of infectious diseases at the VA Pittsburgh Healthcare System.

"It's kind of a no-brainer," he said. "You save people pain, you save people the work of taking care of them, you save money, you save lives and you can export what you learn to other hospital-acquired infections."

Pittsburgh's program has prompted all other major hospital-acquired infections to plummet as well, saving roughly $1 million a year.

"So, how do you pay for it?" Muder asked. "Well, we just don't pay for MRSA infections, that's all."

---

Beth Reimer of Batavia, Ill., became an advocate for MRSA precautions after her 5-week-old daughter Madeline caught a cold that took a fatal turn. One day her beautiful baby had the sniffles. The next?

"She wasn't breathing. She was limp," the mother recalled. "Something was terribly wrong."

MRSA had invaded her little lungs. The were useless. Maddie struggled to breathe, swallow, survive, for two weeks.

"For me to sit and watch Madeline pass away from such an aggressive form of something, to watch her fight for her little life - it was too much," Reimer said.

Since Madeline's death, Reimer has become outspoken about the need for better precautions, pushing for methods successfully used in Norway. She's stunned, she said, that anyone disputes the need for change.

"Why are they fighting for this not to take place?" she said.

Explore further: Scientists discover new clues to how weight loss is regulated

4.7 /5 (44 votes)
add to favorites email to friend print save as pdf

Related Stories

Staph infections carry long-term risks

Jul 03, 2008

Patients who harbor the highly contagious bacterium causing staph infections can develop serious and sometimes deadly symptoms a year or longer after initial detection, a UC Irvine infectious disease researcher has found.

New study finds MRSA on the rise in hospital outpatients

Nov 24, 2009

The community-associated strain of the deadly superbug MRSA -- an infection-causing bacteria resistant to most common antibiotics -- poses a far greater health threat than previously known and is making its way into hospitals, ...

Recommended for you

Growing a blood vessel in a week

10 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

13 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments : 7

Adjust slider to filter visible comments by rank

Display comments: newest first

djoseff
2.3 / 5 (3) Dec 31, 2009
In the US it is, or at least used to be, common agricultural practice to feed quinolones to chickens and beef to accelerate their time to market. This has a known huge influence on the development of antibiotic resistant bugs. The Norway model of restraint is inapplicable to American Medicine.
Planetbob99
3 / 5 (1) Jan 01, 2010
@djoseff: From the text about 8 inches above where you typed your comment "the CDC approached a Veterans Affairs hospital in Pittsburgh.[...] The result: an 80 percent decrease in MRSA infections"

Would this be the VA hospital in Pittsburgh, Norway?
weewilly
not rated yet Jan 01, 2010
We no longer drive Model T cars on America Roads anymore so why would be still be using outdated and non effective anti-biotics? Shouldn't we have been pushing much harder for substitute drug therapy? I know it isn't easy to come up with something new but look what drug costs are today. How much more money is needed for this type of research or is it just being paid out in "C" ranking bonuses and golden parachutes? Something has to be done or we will soon be given hospital patients hammers to protect themselves from these microscopic invaders.
Nik_2213
5 / 5 (1) Jan 02, 2010
WW, for several decades, authorities have been fighting a battle against casual antibiotic misuse. IIRC, there was MASSIVE dosing of cattle and other live-stock, causing eventual medicinal loss of an extended family of drugs, plus lots of hypersensitisation & allergy problems.

Don't forget that bugs generally mutate and adapt faster than researchers can tweak antibiotics. Then there's the long, slow issue of safety testing and clinical trials...

Remember the old argument about a slippery hill: Do you put a boring fence at the top or one (1) snazzy ambulance at the bottom ??

FWIW, we should be pushing for more use of vaccinations and phages: Remember how Tetanus was a common killer ? How Polio was the scourge of countless generations ?? RIP Smallpox ??

Uh, how many of your extended family are well vaccinated ? There's no 100% guarantee of immunity, but your modest precaution stacks the odds in triage...
Nickst99
not rated yet Jan 02, 2010
Everything in this article makes sense, however I can't help feeling like this is more about getting Americans used to the idea that they won't be getting all the drugs they might need in order to save money under the new health care bill. A little like the studies about mamograms being not being cost effective due to false positives.
SteveL
5 / 5 (1) Jan 04, 2010
There is a difference between the drugs people need and the drugs they want. For the last 60 years drugs have been pushed off on society as the answer to whatever ails us. The human body is pretty darn good at taking care of most common variety ills - I say let it. Our immune systems work better when we allow them to work. Yeah, it may take a bit longer to get better, but we will be "better" if our systems have to exercise a bit. This needs to remain a medically educated decision.

That said; it would be helpful to the entire process if business made it worth our while and affordable to stay at home when a doctor recommends it.

As far as this new health care bill goes, a bit more fraud enforcement would go a long ways to keep costs down. I know, as well as many others know people getting benefits that are not needed nor deserved. Every time "The Government" or "Insurance" pays for undeserved benefits it's really you and I footing the bill.
blyster
not rated yet Jan 04, 2010
The medical establishment in this country is to blame for the overuse of medication. Dr's get kickbacks for prescribing medications. That's why doctors give antibiotics to people with viral infections. And this health care bill won't change a thing, In fact it will encourage the status quo. This country has one of the worst health care systems in the world. I'm not referring to any particular doctor or hospital, I'm talking overall health management of patients because it is all driven by money/profit. Health care and profit do not mix.
Paul123
Jan 11, 2010
This comment has been removed by a moderator.